Daniel S. Goldman sold Amicus Therapeutics Inc (NASDAQ: FOLD)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Amicus Therapeutics Inc (FOLD) since 2023, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $1,001 - $15,000 of Amicus Therapeutics Inc (NASDAQ: FOLD) on April 10, 2023. Since that trade, FOLD is up +30.78% against the S&P 500 up +85.07%, an outperformance of -54.29%.
Data updated
Daniel S. Goldman's FOLD trades vs the price
FOLD is up +30.78% since Daniel S. Goldman sold on April 10, 2023, versus +85.07% for the S&P 500.
Performance since this trade
All Daniel S. Goldman FOLD trades
Daniel S. Goldman & FOLD trading FAQ
Is it legal for Daniel S. Goldman to trade Amicus Therapeutics Inc (FOLD) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Amicus Therapeutics Inc (FOLD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell FOLD?
Daniel S. Goldman disclosed a sale of $1,001 - $15,000 of Amicus Therapeutics Inc (FOLD) on April 10, 2023, according to public STOCK Act filings.
How has FOLD performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold FOLD on April 10, 2023, the stock is up +30.78%, versus +85.07% for the S&P 500 over the same period, an outperformance of -54.29%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional FOLD trades?
Quantellect tracks every disclosed congressional trade in Amicus Therapeutics Inc (FOLD) on the Amicus Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's FOLD tradesAll congressional filings for Amicus Therapeutics IncDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.